The abstract is read at the publisher; the summary is JClub's.
Myeloid-specific ZEB1 deletion in hypoxia-induced pulmonary hypertension mice attenuates macrophage inflammation, pulmonary vascular remodeling, and right ventricular dysfunction.
- Why it matters: The transcriptional control of macrophage glutamine metabolism in pulmonary arterial hypertension is not fully defined, limiting targeted therapeutic strategies.
- What they did: Clinical and multiomics analyses linked ZEB1 to disease-associated macrophages, and integrated sequencing, metabolomics, and ChIP-qPCR showed ZEB1 binding the GLS promoter with BRD4 recruitment to enhance histone H3 lysine 27 acetylation and GLS transcription.
- The result: Restoring GLS partially reversed ZEB1-deficiency metabolic and inflammatory effects, and pharmacologic ZEB1 targeting plus BRD4 and GLS inhibition, as well as adenoviral ZEB1 silencing, ameliorated experimental pulmonary hypertension.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.